Daily Brief Podcast
We tackle the health topics no one else wants to touch 💉🧠
—from obesity and high blood pressure
—to emotional eating and medication resistance
—to cultural myths that keep people sick 🧬❌
My mission is to deliver evidence-based truth—
real doctors. hard truths. no coddling. 🎯
🎧 Subscribe now and share with someone who’s tired of watered-down wellness.
Let’s change lives with facts—not fluff.
Daily Brief Podcast
Ozempic Is Science, Not Opinion
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, I discuss why GLP 1 medications like Ozempic, Wegovy, Mounjaro, and ZepBound should be treated as science, not opinion. Through Melissa’s story, I explain how some patients are dismissed before they ever get a fair discussion about weight loss treatment. I also break down the evidence behind these medications, the prescribing challenges doctors face, and the access barriers that keep many eligible patients from receiving care. The episode closes with practical advice on how patients can ask better questions, seek second opinions, and find physicians who are prepared to support long term obesity treatment.
💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/